An updated overview of anticancer effects of alternariol and its derivatives: underlying molecular mechanisms.

Muhammad Torequl Islam, Miquel Martorell, Carlos González-Contreras, Marcelo Villagran, Lorena Mardones, Bekzat Tynybekov, Anca Oana Docea, Ahmad Faizal Abdull Razis, Babagana Modu, Daniela Calina, Javad Sharifi-Rad
Author Information
  1. Muhammad Torequl Islam: Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
  2. Miquel Martorell: Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepción, Concepción, Chile.
  3. Carlos González-Contreras: Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepción, Concepción, Chile.
  4. Marcelo Villagran: Biomedical Sciences Research Laboratory, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción, Chile.
  5. Lorena Mardones: Biomedical Sciences Research Laboratory, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción, Chile.
  6. Bekzat Tynybekov: Department of Biodiversity of Bioresources, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
  7. Anca Oana Docea: Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  8. Ahmad Faizal Abdull Razis: Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Selangor, Malaysia.
  9. Babagana Modu: Natural Medicines and Products Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Selangor, Malaysia.
  10. Daniela Calina: Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  11. Javad Sharifi-Rad: Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador.

Abstract

alternariol is a toxic metabolite of Alternaria fungi and studies have shown multiple potential pharmacological effects. To outline the anticancer effects and mechanisms of alternariol and its derivatives based on database reports, an updated search of PubMed/MedLine, ScienceDirect, Web of Science, and Scopus databases was performed with relevant keywords for published articles. The studies found to suggest that this mycotoxin and/or its derivatives have potential anticancer effects in many pharmacological preclinical test systems. Scientific reports indicate that alternariol and/or its derivatives exhibit anticancer through several pathways, including cytotoxic, reactive oxygen species leading to oxidative stress and mitochondrial dysfunction-linked cytotoxic effect, anti-inflammatory, cell cycle arrest, apoptotic cell death, genotoxic and mutagenic, anti-proliferative, autophagy, and estrogenic and clastogenic mechanisms. In light of these results, alternariol may be one of the hopeful chemotherapeutic agents.

Keywords

References

  1. Rom J Morphol Embryol. 2012;53(3 Suppl):683-92 [PMID: 23188426]
  2. Toxicol Lett. 2008 Nov 10;182(1-3):57-62 [PMID: 18790025]
  3. Food Chem Toxicol. 2006 Mar;44(3):398-408 [PMID: 16194592]
  4. Molecules. 2019 Jul 04;24(13): [PMID: 31277407]
  5. Int J Mol Sci. 2017 Jul 20;18(7): [PMID: 28726766]
  6. Plants (Basel). 2022 Jul 20;11(14): [PMID: 35890519]
  7. Bioorg Med Chem. 2019 Feb 1;27(3):516-524 [PMID: 30617018]
  8. Arch Toxicol. 2018 Nov;92(11):3347-3358 [PMID: 30175388]
  9. Int J Mol Sci. 2016 Nov 22;17(11): [PMID: 27879664]
  10. Toxins (Basel). 2019 Sep 03;11(9): [PMID: 31484408]
  11. Mutat Res Genet Toxicol Environ Mutagen. 2016 Mar;798-799:27-34 [PMID: 26994491]
  12. Toxins (Basel). 2016 Mar 26;8(4):94 [PMID: 27023609]
  13. IUBMB Life. 2018 Nov;70(11):1084-1092 [PMID: 30180298]
  14. Oxid Med Cell Longev. 2021 Dec 28;2021:1602437 [PMID: 34992714]
  15. Cells. 2019 Jul 03;8(7): [PMID: 31277291]
  16. Mutat Res Genet Toxicol Environ Mutagen. 2022 Jan;873:503435 [PMID: 35094809]
  17. Mol Nutr Food Res. 2019 Oct;63(20):e1900341 [PMID: 31584250]
  18. Mol Immunol. 2023 Jan;153:126-134 [PMID: 36495817]
  19. Front Oncol. 2023 Jan 09;12:1068778 [PMID: 36698404]
  20. Toxicol Lett. 2015 Jun 1;235(2):61-6 [PMID: 25827405]
  21. FEBS Lett. 2019 Oct;593(20):2853-2867 [PMID: 31556113]
  22. J Pers Med. 2022 Sep 15;12(9): [PMID: 36143299]
  23. EFSA J. 2019 Nov 05;17(11):e05860 [PMID: 32626161]
  24. Mol Nutr Food Res. 2009 Apr;53(4):441-51 [PMID: 18727009]
  25. Biomed Pharmacother. 2022 Oct;154:113555 [PMID: 36027610]
  26. Cancer Cell Int. 2022 Oct 7;22(1):305 [PMID: 36207736]
  27. Biomed Res Int. 2022 Jul 5;2022:5886269 [PMID: 35837379]
  28. Cancer Cell Int. 2022 Aug 8;22(1):246 [PMID: 35941592]
  29. Cancer Cell Int. 2022 Nov 15;22(1):354 [PMID: 36376956]
  30. Toxicol Appl Pharmacol. 2013 Aug 15;271(1):64-71 [PMID: 23665424]
  31. Oncol Lett. 2019 May;17(5):4094-4101 [PMID: 30944602]
  32. Molecules. 2021 Dec 04;26(23): [PMID: 34885945]
  33. Cancer Cell Int. 2022 Jul 28;22(1):239 [PMID: 35902860]
  34. Cells. 2020 Mar 31;9(4): [PMID: 32244540]
  35. Oxid Med Cell Longev. 2021 Oct 18;2021:3687700 [PMID: 34707776]
  36. Biomed Pharmacother. 2023 Apr;160:114332 [PMID: 36736282]
  37. Front Nutr. 2021 Jul 16;8:664197 [PMID: 34336908]
  38. Cancer Cell Int. 2022 Dec 13;22(1):407 [PMID: 36514100]
  39. Mutat Res. 2006 Jul 14;606(1-2):61-71 [PMID: 16698312]
  40. Int J Food Microbiol. 2019 Mar 2;292:48-55 [PMID: 30572265]
  41. Environ Toxicol Pharmacol. 2017 Oct;55:208-211 [PMID: 28910742]
  42. Toxicol Lett. 2009 Apr 25;186(2):139-45 [PMID: 19429235]
  43. Arch Toxicol. 2012 Apr;86(4):625-32 [PMID: 22120949]
  44. Toxicology. 2014 Dec 4;326:119-29 [PMID: 25456271]
  45. Toxicol Lett. 2014 Sep 17;229(3):458-64 [PMID: 25072143]
  46. Mycotoxin Res. 2009 Oct;25(3):149-57 [PMID: 23605094]
  47. Toxicol Rep. 2019 Jul 17;6:745-758 [PMID: 31406682]
  48. Toxins (Basel). 2020 Sep 30;12(10): [PMID: 33008111]
  49. Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):533-539 [PMID: 27341187]
  50. Appl Environ Microbiol. 1983 Dec;46(6):1420-2 [PMID: 6686430]
  51. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jul;60(7):745-756 [PMID: 28508953]
  52. Rom J Morphol Embryol. 2015;56(1):175-81 [PMID: 25826503]
  53. Toxicol Res (Camb). 2021 Jun 16;10(4):719-732 [PMID: 34484663]
  54. Evid Based Complement Alternat Med. 2022 Mar 7;2022:6727609 [PMID: 35295925]
  55. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647 [PMID: 35397795]
  56. Toxicol Lett. 2013 Jan 10;216(1):23-30 [PMID: 23154127]
  57. Toxicol Lett. 2006 Jul 14;164(3):221-30 [PMID: 16464542]
  58. J Oncol. 2021 Dec 10;2021:5905357 [PMID: 34925509]
  59. Food Chem Toxicol. 2015 Mar;77:44-9 [PMID: 25542527]
  60. Mycotoxin Res. 2007 Sep;23(3):152-7 [PMID: 23605994]
  61. Cancer Cell Int. 2022 Sep 15;22(1):284 [PMID: 36109789]
  62. Oxid Med Cell Longev. 2021 Jul 19;2021:3268136 [PMID: 34336089]
  63. J Basic Microbiol. 2015 Jul;55(7):805-18 [PMID: 25682759]
  64. Evid Based Complement Alternat Med. 2022 Feb 24;2022:4024331 [PMID: 35251206]
  65. Cancer Cell Int. 2022 Aug 15;22(1):257 [PMID: 35971151]
  66. Environ Health Perspect. 1973 Jun;4:87-94 [PMID: 4198474]
  67. Oncol Lett. 2019 May;17(5):4170-4175 [PMID: 30944612]
  68. Compr Rev Food Sci Food Saf. 2021 Sep;20(5):4390-4406 [PMID: 34323368]
  69. Food Chem. 2018 Apr 15;245:951-957 [PMID: 29287464]
  70. Cancer Cell Int. 2021 Jun 24;21(1):318 [PMID: 34167552]
  71. Cancer Cell Int. 2022 Sep 8;22(1):280 [PMID: 36076273]
  72. J Pers Med. 2021 May 31;11(6): [PMID: 34072930]
  73. Toxicon. 2015 Jan;93:103-11 [PMID: 25451539]
  74. Biomed Environ Sci. 1996 Mar;9(1):67-70 [PMID: 8721630]
  75. Front Cell Dev Biol. 2022 Sep 29;10:1005910 [PMID: 36247004]
  76. Front Pharmacol. 2021 Jan 18;11:592654 [PMID: 33536909]
  77. Oxid Med Cell Longev. 2021 Dec 10;2021:6349041 [PMID: 34925698]
  78. Oxid Med Cell Longev. 2021 Dec 31;2021:6584693 [PMID: 39071243]
  79. Cancer Cell Int. 2022 Jun 2;22(1):206 [PMID: 35655306]
  80. Food Chem Toxicol. 2016 Mar;89:60-6 [PMID: 26802676]
  81. J Appl Microbiol. 2019 Nov;127(5):1468-1478 [PMID: 31403229]
  82. Mutat Res. 2012 Oct-Nov;738-739:1-11 [PMID: 23031795]
  83. Int J Mol Sci. 2021 Dec 02;22(23): [PMID: 34884865]
  84. Toxicol Lett. 2013 May 10;219(1):8-17 [PMID: 23454835]
  85. Toxicol In Vitro. 2012 Sep;26(6):915-23 [PMID: 22542754]
  86. Toxicology. 2019 Jan 15;412:79-88 [PMID: 30503586]
  87. Int J Environ Res Public Health. 2020 Mar 30;17(7): [PMID: 32235611]
  88. Biomed Pharmacother. 2023 Feb;158:114145 [PMID: 36586242]
  89. Toxicology. 2011 Dec 18;290(2-3):230-40 [PMID: 22001388]
  90. Toxicol Lett. 2012 Oct 2;214(1):27-32 [PMID: 22902351]
  91. Food Chem. 2015 Dec 15;189:93-101 [PMID: 26190606]

Word Cloud

Created with Highcharts 10.0.0alternarioleffectsanticancermechanismsderivativescytotoxicstudiespotentialpharmacologicalreportsupdatedmycotoxinand/oreffectcellmolecularAlternarioltoxicmetaboliteAlternariafungishownmultipleoutlinebaseddatabasesearchPubMed/MedLineScienceDirectWebScienceScopusdatabasesperformedrelevantkeywordspublishedarticlesfoundsuggestmanypreclinicaltestsystemsScientificindicateexhibitseveralpathwaysincludingreactiveoxygenspeciesleadingoxidativestressmitochondrialdysfunction-linkedanti-inflammatorycyclearrestapoptoticdeathgenotoxicmutagenicanti-proliferativeautophagyestrogenicclastogeniclightresultsmayonehopefulchemotherapeuticagentsoverviewderivatives:underlyingapoptosiscancerchemotherapytargets

Similar Articles

Cited By (7)